$17.25
1.116.88%
In chiusura: -
$17.00
-0.25-1.45%
After hour: Aug 22, 6:47 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
OptimizeRx segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 12
Stima EPS
$0.086
Stima dei ricavi trimestrali
$24.68M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$104.75M
Analizza lo storico degli utili di OptimizeRx utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
OPRX | OptimizeRx | $0.12 | $0.09 | — | — | $21.31M | $24.68M | — | — | 11/12/2025 | |
OPRX | OptimizeRx | $0.02 | $0.02 | $0.24 | 900.00% | $18.81M | $22.26M | $29.20M | 30.88% | 08/07/2025 | |
OPRX | OptimizeRx | -$0.11 | -$0.12 | $0.08 | 166.67% | $19.69M | $18.69M | $21.93M | 17.32% | 05/12/2025 | |
OPRX | OptimizeRx | $0.26 | $0.27 | $0.30 | 11.11% | $28.40M | $30.36M | $32.32M | 6.45% | 03/12/2025 | |
OPRX | OptimizeRx | $0.09 | $0.06 | $0.12 | 100.00% | $16.33M | $25.00M | $21.31M | -14.76% | 11/13/2024 | |
OPRX | OptimizeRx | -$0.01 | -$0.06 | $0.02 | 133.33% | $13.82M | $20.20M | $18.81M | -6.92% | 08/08/2024 | |
OPRX | OptimizeRx | -$0.09 | -$0.13 | -$0.11 | 15.38% | $13.00M | $18.13M | $19.69M | 8.60% | 05/14/2024 | |
OPRX | OptimizeRx | $0.25 | $0.26 | $0.26 | 0.00% | $19.65M | $26.47M | $28.37M | 7.17% | 04/16/2024 | |
OPRX | OptimizeRx | $0.07 | $0.00 | $0.09 | 100.00% | $15.09M | $15.01M | $16.33M | 8.80% | 11/06/2023 | |
OPRX | OptimizeRx | $0.04 | -$0.02 | -$0.01 | 50.00% | $13.98M | $14.81M | $13.82M | -6.70% | 08/14/2023 | |
OPRX | OptimizeRx | -$0.01 | -$0.08 | -$0.09 | -12.50% | $13.73M | $12.35M | $13.00M | 5.29% | 05/10/2023 | |
OPRX | OptimizeRx | $0.22 | $0.24 | $0.25 | 4.17% | $20.31M | $21.77M | $19.65M | -9.72% | 03/08/2023 | |
OPRX | OptimizeRx | $0.09 | $0.04 | $0.07 | 75.00% | $16.13M | $15.02M | $15.09M | 0.44% | 11/08/2022 | |
OPRX | OptimizeRx | $0.10 | $0.09 | $0.04 | -55.56% | $13.63M | $16.87M | $13.98M | -17.14% | 08/09/2022 | |
OPRX | OptimizeRx | $0.03 | -$0.01 | -$0.01 | 0.00% | $11.23M | $13.97M | $13.73M | -1.70% | 05/04/2022 | |
OPRX | OptimizeRx | $0.16 | $0.20 | $0.22 | 10.00% | $16.43M | $20.16M | $20.31M | 0.76% | 02/24/2022 | |
OPRX | OptimizeRx | $0.07 | $0.13 | $0.09 | -30.77% | $10.52M | $15.06M | $16.13M | 7.07% | 11/09/2021 | |
OPRX | OptimizeRx | $0.02 | $0.07 | $0.10 | 42.86% | $8.78M | $12.45M | $13.63M | 9.45% | 08/04/2021 | |
OPRX | OptimizeRx | -$0.06 | $0.01 | $0.03 | 200.00% | $7.58M | $10.47M | $11.23M | 7.25% | 05/06/2021 | |
OPRX | OptimizeRx | -$0.03 | $0.15 | $0.16 | 6.67% | $7.38M | $16.02M | $16.43M | 2.53% | 02/24/2021 | |
OPRX | OptimizeRx | -$0.05 | $0.04 | $0.07 | 75.00% | $5.00M | $9.77M | $10.52M | 7.67% | 11/09/2020 |
OptimizeRx (OPRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $0.24 | $0.02 | 900.0 % |
| Q1 | 2025-05-12 | $0.08 | $-0.12 | 166.7 % |
| Q4 | 2025-03-12 | $0.30 | $0.27 | 11.1 % |
| Q3 | 2024-11-13 | $0.12 | $0.06 | 100.0 % |
OptimizeRx (OPRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $29.20M | $22.26M | 30.9 % |
| Q1 | 2025-05-12 | $21.93M | $18.69M | 17.3 % |
| Q4 | 2025-03-12 | $32.32M | $30.36M | 6.45 % |
| Q3 | 2024-11-13 | $21.31M | $25.00M | -14.8 % |
FAQ
Quando OptimizeRx (NASDAQ:OPRX) riporterà gli utili?
Si prevede che OptimizeRx (OPRX) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di OptimizeRx (NASDAQ:OPRX)?
L'EPS effettivo era $0.24, che superato la stima di $0.02.
Quali sono state le entrate di OptimizeRx (NASDAQ:OPRX)?
Le entrate effettive sono state $29.2M, che superato la stima di $22.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.